These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
132 related items for PubMed ID: 14640894
1. The influence of nitric oxide synthase inhibitor L-NAME on bones of male rats with streptozotocin-induced diabetes. Broulík PD, Haluzík M, Skrha J. Physiol Res; 2003; 52(6):729-34. PubMed ID: 14640894 [Abstract] [Full Text] [Related]
2. Osteopenia: a bone disorder associated with diabetes mellitus. Duarte VM, Ramos AM, Rezende LA, Macedo UB, Brandão-Neto J, Almeida MG, Rezende AA. J Bone Miner Metab; 2005; 23(1):58-68. PubMed ID: 15616896 [Abstract] [Full Text] [Related]
3. Effect of alendronate administration on bone mineral density and bone strength in castrated rats. Broulik PD, Rosenkrancová J, Růzicka P, Sedlácek R. Horm Metab Res; 2005 Jul; 37(7):414-8. PubMed ID: 16034712 [Abstract] [Full Text] [Related]
5. Role of nitric oxide in renal function in rats with short and prolonged periods of streptozotocin-induced diabetes. Suanarunsawat T, Klongpanichapak S, Chaiyabutr N. Diabetes Obes Metab; 1999 Nov; 1(6):339-46. PubMed ID: 11225650 [Abstract] [Full Text] [Related]
9. Curcumin suppresses increased bone resorption by inhibiting osteoclastogenesis in rats with streptozotocin-induced diabetes. Hie M, Yamazaki M, Tsukamoto I. Eur J Pharmacol; 2009 Oct 25; 621(1-3):1-9. PubMed ID: 19699734 [Abstract] [Full Text] [Related]
11. Role of nitric oxide in the pathogenesis of diabetic nephropathy in streptozotocin-induced diabetic rats. Choi KC, Lee SC, Kim SW, Kim NH, Lee JU, Kang YJ. Korean J Intern Med; 1999 Jan 25; 14(1):32-41. PubMed ID: 10063312 [Abstract] [Full Text] [Related]
12. Prevention of corticosteroid-induced bone loss with nitric oxide donor nitroglycerin in male rats. Wimalawansa SJ, Chapa MT, Yallampalli C, Zhang R, Simmons DJ. Bone; 1997 Sep 25; 21(3):275-80. PubMed ID: 9276093 [Abstract] [Full Text] [Related]
15. Effect of nitric oxide synthase inhibitors on bone metabolism in growing rats. Tsukahara H, Miura M, Tsuchida S, Hata I, Hata K, Yamamoto K, Ishii Y, Muramatsu I, Sudo M. Am J Physiol; 1996 May 25; 270(5 Pt 1):E840-5. PubMed ID: 8967473 [Abstract] [Full Text] [Related]
17. Treatment with the NO-synthase inhibitor, methylene blue, moderates the decrease in serum leptin concentration in streptozotocin-induced diabetes. Haluzik M, Nedvídková J, Skrha J. Endocr Res; 1999 May 25; 25(2):163-71. PubMed ID: 10382678 [Abstract] [Full Text] [Related]
18. An analysis of renal nitric oxide contribution to hyperfiltration in diabetic rats. Schwartz D, Schwartz IF, Blantz RC. J Lab Clin Med; 2001 Feb 25; 137(2):107-14. PubMed ID: 11174467 [Abstract] [Full Text] [Related]
19. Dietary xylitol supplementation prevents osteoporotic changes in streptozotocin-diabetic rats. Mattila PT, Knuuttila ML, Svanberg MJ. Metabolism; 1998 May 25; 47(5):578-83. PubMed ID: 9591750 [Abstract] [Full Text] [Related]
20. Effect of inhibition of nitric oxide synthase on renal cyclooxygenase in the diabetic rat. Chen YJ, Li J, Quilley J. Eur J Pharmacol; 2006 Jul 10; 541(1-2):80-6. PubMed ID: 16753143 [Abstract] [Full Text] [Related] Page: [Next] [New Search]